United States Pharmaceuticals

2Seventy Bio Inc (TSVT)

Track

Ticker: TSVT Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for 2Seventy Bio Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 17 Mar 2025
Value US$1,927,090.45 | Price 60.28 | Shares 69,882 (-2.5%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-19 2025-03-17 S Sale
2.8
Eatwell Victoria

Chief Financial Officer

Officer
69,882 -2.5%
60.28
US$1,927,090 		69,882 -2.5% 60.28 US$1,927,090
2025-03-19 2025-03-17 S Sale
3.5
Baird William D III

President and CEO

Executive Director
91,116 -31.5%
146.41
US$1,171,648 		91,116 -31.5% 146.41 US$1,171,648
2025-03-19 2025-03-17 S Sale
2.9
Snow Jessica

Chief Operating Officer

Officer
19,560 -1.1%
385.50
US$503,761 		19,560 -1.1% 385.50 US$503,761
2025-03-13 2025-03-11 S Sale
0.9
Kynam Global Healthcare Master Fund, LP
Large shareholder
5,142,111 -100.0%
4.93
US$25,350,607 		5,142,111 -100.0% 4.93 US$25,350,607
2025-03-13 2025-03-11 S Sale
0.9
Kynam Global Healthcare Master Fund, LP
Large shareholder
5,142,111 -100.0%
4.93
US$25,350,607 		5,142,111 -100.0% 4.93 US$25,350,607
2025-03-13 2025-03-11 S Sale
0.9
Kynam Global Healthcare Master Fund, LP
Large shareholder
5,953,825 -100.0%
4.93
US$29,352,357 		5,953,825 -100.0% 4.93 US$29,352,357
2025-01-07 2025-01-07 PlS Planned sale
2.9
Snow Jessica

See Remarks

Officer
186 -0.1%
2.64
US$491 		186 -0.1% 2.64 US$491
2025-01-07 2025-01-06 S Sale
3.2
Leschly Nick
Non-Executive Director
892 -0.1%
2.78
US$2,478 		892 -0.1% 2.78 US$2,478
2025-01-07 2025-01-06 PlS Planned sale
2.9
Snow Jessica

See Remarks

Officer
5,000 -3.3%
2.79
US$13,972 		5,000 -3.3% 2.79 US$13,972
2025-01-07 2025-01-06 S Sale
2.9
Snow Jessica

See Remarks

Officer
114 -0.1%
2.78
US$317 		114 -0.1% 2.78 US$317
2025-01-07 2025-01-06 S Sale
3.5
Baird William D III

President and CEO

Executive Director
763 -0.1%
2.78
US$2,120 		763 -0.1% 2.78 US$2,120
2025-01-07 2025-01-06 S Sale
2.8
Eatwell Victoria

Chief Financial Officer

Officer
97 -0.0%
2.78
US$270 		97 -0.0% 2.78 US$270
2025-01-07 2025-01-03 S Sale
3.2
Leschly Nick
Non-Executive Director
85,978 -6.5%
2.94
US$252,423 		85,978 -6.5% 2.94 US$252,423
2025-01-07 2025-01-03 S Sale
2.9
Snow Jessica

See Remarks

Officer
1,000 -0.7%
2.94
US$2,936 		1,000 -0.7% 2.94 US$2,936
2025-01-07 2025-01-03 S Sale
3.5
Baird William D III

President and CEO

Executive Director
31,718 -3.5%
2.94
US$93,121 		31,718 -3.5% 2.94 US$93,121
2025-01-07 2025-01-03 S Sale
2.8
Eatwell Victoria

Chief Financial Officer

Officer
1,013 -0.3%
2.94
US$2,974 		1,013 -0.3% 2.94 US$2,974
2024-12-17 2024-12-13 PlS Planned sale
2.9
Snow Jessica

See Remarks

Officer
2,287 -1.5%
3.23
US$7,393 		2,287 -1.5% 3.23 US$7,393
2024-12-13 2024-12-13 PrS Proposed sale
2.9
JESSICA C SNOW

Officer

Officer
10,341
3.34
US$34,539 		10,341 3.34 US$34,539
2024-11-20 2024-11-18 S Sale
2.3
Maus Marcela V.
Non-Executive Director
3,900 -14.1%
3.38
US$13,182 		3,900 -14.1% 3.38 US$13,182
2024-11-18 2024-11-18 PrS Proposed sale
2.3
MARCELA MAUS

Director

Non-Executive Director
3,900
3.38
US$13,182 		3,900 3.38 US$13,182
2024-10-07 2024-10-03 PlS Planned sale
2.9
Snow Jessica

See Remarks

Officer
679 -0.4%
4.65
US$3,157 		679 -0.4% 4.65 US$3,157
2024-10-07 2024-10-03 S Sale
2.8
Eatwell Victoria

Chief Financial Officer

Officer
1,230 -0.4%
4.65
US$5,718 		1,230 -0.4% 4.65 US$5,718
2024-08-16 2024-08-14 S Sale
2.9
Snow Jessica

See Remarks

Officer
7,816 -4.8%
4.32
US$33,760 		7,816 -4.8% 4.32 US$33,760
2024-08-14 2024-08-14 PrS Proposed sale
2.9
JESSICA SNOW

Officer

Officer
7,816
4.32
US$33,760 		7,816 4.32 US$33,760
2024-08-07 2024-08-05 S Sale
2.8
Eatwell Victoria

Chief Financial Officer

Officer
13 -0.0%
3.99
US$52 		13 -0.0% 3.99 US$52
2024-07-03 2024-07-02 S Sale
2.8
Eatwell Victoria

Chief Financial Officer

Officer
12 -0.0%
4.02
US$48 		12 -0.0% 4.02 US$48
2024-07-03 2024-07-02 S Sale
2.9
Snow Jessica

See Remarks

Officer
14 -0.0%
4.02
US$56 		14 -0.0% 4.02 US$56
2024-06-05 2024-06-03 S Sale
2.9
Snow Jessica

See Remarks

Officer
649 -1.2%
4.18
US$2,714 		649 -1.2% 4.18 US$2,714
2024-06-05 2024-06-03 S Sale
2.8
Eatwell Victoria

Chief Financial Officer

Officer
1,167 -1.2%
4.18
US$4,881 		1,167 -1.2% 4.18 US$4,881
2024-05-16 2024-05-03 S Sale
2.9
Snow Jessica

See Remarks

Officer
15 -0.0%
4.91
US$74 		15 -0.0% 4.91 US$74
2024-03-28 2024-03-26 B Purchase
3.2
Casdin Capital, LLC
Non-Executive Director
40,000 +2.0%
5.10
US$203,992 		40,000 +2.0% 5.10 US$203,992
2024-03-25 2024-03-25 B Purchase
3.2
Casdin Capital, LLC
Non-Executive Director
330,000 +20.2%
5.07
US$1,673,991 		330,000 +20.2% 5.07 US$1,673,991
2024-03-25 2024-03-22 B Purchase
3.2
Casdin Capital, LLC
Non-Executive Director
147,377 +9.9%
5.12
US$754,069 		147,377 +9.9% 5.12 US$754,069
2024-03-25 2024-03-21 B Purchase
3.2
Casdin Capital, LLC
Non-Executive Director
300,000 +25.4%
4.90
US$1,470,990 		300,000 +25.4% 4.90 US$1,470,990
2024-01-09 2024-01-05 S Sale
3.3
Gregory Philip D

Chief Scientific Officer

Officer
795 -0.3%
3.75
US$2,984 		795 -0.3% 3.75 US$2,984
2024-01-09 2024-01-05 S Sale
3.5
Baird William D III

Chief Operating Officer

Officer
1,380 -0.8%
3.75
US$5,180 		1,380 -0.8% 3.75 US$5,180
2024-01-09 2024-01-05 S Sale
3.2
Leschly Nick

President and CEO

Executive Director
1,554 -0.1%
3.75
US$5,833 		1,554 -0.1% 3.75 US$5,833
2024-01-05 2024-01-03 S Sale
3.3
Gregory Philip D

Chief Scientific Officer

Officer
25,613 -10.0%
3.87
US$99,084 		25,613 -10.0% 3.87 US$99,084
2024-01-05 2024-01-03 S Sale
3.2
Leschly Nick

President and CEO

Executive Director
72,312 -6.2%
3.87
US$279,739 		72,312 -6.2% 3.87 US$279,739
2024-01-05 2024-01-03 S Sale
3.5
Baird William D III

Chief Operating Officer

Officer
33,651 -17.1%
3.87
US$130,179 		33,651 -17.1% 3.87 US$130,179
2023-08-24 2023-08-22 S Sale
3.5
Baird William D III

Chief Financial Officer

Officer
7,031 -3.5%
5.49
US$38,576 		7,031 -3.5% 5.49 US$38,576
2023-08-24 2023-08-22 S Sale
3.2
Leschly Nick

President and CEO

Executive Director
9,312 -0.8%
5.49
US$51,090 		9,312 -0.8% 5.49 US$51,090
2023-08-24 2023-08-22 S Sale
3.3
Gregory Philip D

Chief Scientific Officer

Officer
6,159 -2.3%
5.49
US$33,791 		6,159 -2.3% 5.49 US$33,791
2023-08-16 2023-08-10 B Purchase
0.9
Kynam Global Healthcare Master Fund, LP
Large shareholder
86,414 +1.7%
5.96
US$515,027 		86,414 +1.7% 5.96 US$515,027
2023-08-16 2023-08-10 B Purchase
0.9
Kynam Global Healthcare Master Fund, LP
Large shareholder
86,414 +1.7%
5.96
US$515,027 		86,414 +1.7% 5.96 US$515,027
2023-08-16 2023-08-10 B Purchase
0.9
Kynam Global Healthcare Master Fund, LP
Large shareholder
100,000 +1.7%
5.96
US$596,000 		100,000 +1.7% 5.96 US$596,000
2023-08-16 2023-08-10 B Purchase
0.9
Kynam Global Healthcare Master Fund, LP
Large shareholder
100,000 +1.7%
5.85
US$585,000 		100,000 +1.7% 5.85 US$585,000
2023-08-16 2023-08-10 B Purchase
0.9
Kynam Global Healthcare Master Fund, LP
Large shareholder
50,000 +0.9%
5.80
US$290,000 		50,000 +0.9% 5.80 US$290,000
2023-08-16 2023-08-10 B Purchase
0.9
Kynam Global Healthcare Master Fund, LP
Large shareholder
179,000 +3.2%
5.94
US$1,063,260 		179,000 +3.2% 5.94 US$1,063,260
2023-08-14 2023-08-10 B Purchase
0.5
Kynam Capital Management, LP
Large shareholder
86,414 +1.7%
5.96
US$515,027 		86,414 +1.7% 5.96 US$515,027
2023-08-14 2023-08-10 B Purchase
0.5
Kynam Capital Management, LP
Large shareholder
86,414 +1.7%
5.96
US$515,027 		86,414 +1.7% 5.96 US$515,027
2023-08-14 2023-08-10 B Purchase
0.5
Kynam Capital Management, LP
Large shareholder
100,000 +1.7%
5.96
US$596,000 		100,000 +1.7% 5.96 US$596,000
2023-08-14 2023-08-10 B Purchase
0.5
Kynam Capital Management, LP
Large shareholder
100,000 +1.7%
5.85
US$585,000 		100,000 +1.7% 5.85 US$585,000
2023-08-14 2023-08-10 B Purchase
0.5
Kynam Capital Management, LP
Large shareholder
50,000 +0.9%
5.80
US$290,000 		50,000 +0.9% 5.80 US$290,000
2023-08-14 2023-08-10 B Purchase
0.5
Kynam Capital Management, LP
Large shareholder
179,000 +3.2%
5.94
US$1,063,260 		179,000 +3.2% 5.94 US$1,063,260
2023-08-07 2023-08-03 S Sale
3.3
Gregory Philip D

Chief Scientific Officer

Officer
3,966 -1.5%
6.13
US$24,295 		3,966 -1.5% 6.13 US$24,295
2023-08-07 2023-08-03 S Sale
3.2
Leschly Nick

President and CEO

Executive Director
9,060 -0.8%
6.13
US$55,499 		9,060 -0.8% 6.13 US$55,499
2023-08-07 2023-08-03 S Sale
3.5
Baird William D III

Chief Financial Officer

Officer
6,906 -3.3%
6.13
US$42,304 		6,906 -3.3% 6.13 US$42,304
2023-02-15 2023-02-13 S Sale
3.5
Baird William D III

Chief Financial Officer

Officer
637 -0.3%
12.86
US$8,192 		637 -0.3% 12.86 US$8,192
2023-02-09 2023-02-07 S Sale
4.0
Heffron Nicola

Chief Operating Officer

Officer
60 -0.1%
14.70
US$882 		60 -0.1% 14.70 US$882
2023-01-17 2023-01-12 S Sale
3.2
Leschly Nick

President and CEO

Executive Director
6,587 -1.2%
10.46
US$68,889 		6,587 -1.2% 10.46 US$68,889
2023-01-18 2023-01-11 S Sale
4.0
Heffron Nicola

Chief Operating Officer

Officer
128 -0.1%
10.63
US$1,360 		128 -0.1% 10.63 US$1,360
2023-01-18 2023-01-11 S Sale
3.3
Gregory Philip D

Chief Scientific Officer

Officer
1,076 -1.1%
10.63
US$11,436 		1,076 -1.1% 10.63 US$11,436
2023-01-18 2023-01-11 S Sale
3.5
Baird William D III

Chief Financial Officer

Officer
1,077 -1.3%
10.63
US$11,446 		1,077 -1.3% 10.63 US$11,446
2023-01-18 2023-01-11 S Sale
3.2
Leschly Nick

President and CEO

Executive Director
2,026 -0.4%
10.63
US$21,533 		2,026 -0.4% 10.63 US$21,533
2023-01-11 2023-01-09 S Sale
3.3
Gregory Philip D

Chief Scientific Officer

Officer
3,794 -3.6%
10.33
US$39,210 		3,794 -3.6% 10.33 US$39,210
2023-01-11 2023-01-09 S Sale
3.2
Leschly Nick

President and CEO

Executive Director
2,979 -0.5%
10.33
US$30,787 		2,979 -0.5% 10.33 US$30,787
2023-01-11 2023-01-09 S Sale
4.0
Heffron Nicola

Chief Operating Officer

Officer
584 -0.6%
10.33
US$6,035 		584 -0.6% 10.33 US$6,035
2023-01-11 2023-01-09 S Sale
3.5
Baird William D III

Chief Financial Officer

Officer
3,222 -3.9%
10.33
US$33,298 		3,222 -3.9% 10.33 US$33,298
2022-12-06 2022-12-05 S Sale
4.0
Heffron Nicola

Chief Operating Officer

Officer
272 -0.3%
15.43
US$4,198 		272 -0.3% 15.43 US$4,198
2022-11-23 2022-11-21 S Sale
4.0
Heffron Nicola

Chief Operating Officer

Officer
7,697 -7.9%
13.97
US$107,527 		7,697 -7.9% 13.97 US$107,527
2022-08-08 2022-08-05 S Sale
3.3
Gregory Philip D

Chief Scientific Officer

Officer
2,407 -2.3%
16.23
US$39,072 		2,407 -2.3% 16.23 US$39,072
2022-08-08 2022-08-05 S Sale
3.2
Leschly Nick

President and CEO

Executive Director
5,499 -1.0%
16.23
US$89,263 		5,499 -1.0% 16.23 US$89,263
2022-08-08 2022-08-05 S Sale
3.5
Baird William D III

Chief Financial Officer

Officer
4,152 -4.8%
16.23
US$67,397 		4,152 -4.8% 16.23 US$67,397
2022-07-19 2022-07-15 S Sale
3.2
Leschly Nick

President and CEO

Executive Director
5,404 -1.0%
13.81
US$74,629 		5,404 -1.0% 13.81 US$74,629
Explore more

More insider trading research around 2Seventy Bio Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America